20. November 2017. | Pneumonia Vaccine

India's decision to give unmerited patent on pneumonia vaccine limits access

MSF urges India to rethink their decision solidifying Pfizer's monopoly on critical pneumonia vaccines, depriving countless children of the opportunity to be protected against pneumonia. Read more
Photo by Yann Libessart